Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Long-Term Efficacy of Efgartigimod PH20 SC in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Interim Results from the ADHERE+ Study

              Author:Allen, Jeffrey   Lin, Jie   Stettner, Mark   Guptill, Jeffrey   Gwathmey, Kelly   Istas, Geoffrey   De Roeck, Arne   Kuwabara, Satoshi   Lauria, Giuseppe   Querol, Luis   Suresh, Niraja   Karam, Chafic   Skripuletz, Thomas   Rinaldi, Simon   Echaniz-Laguna, Andoni   Van Hoorick, Benja   

              Session Name:S16: Updates on Nerve and Muscle Disorders  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:S16.002  

              Author Institution:UMN, Minneapolis, MN  Fudan University, Shanghai, China, People's Republic of  University Medicine Essen, Essen, Germany  Duke University, Durhamn, NC  VCU Neuroscience, Orthopedic, and Wellness, Henrico, VA  argenx, Ghent, Belgium  Chiba University, Chiba, Japan  Istituto Neurologico Carlo Besta, Milan, Italy  Hospital de la Santa Creu i Sant Pau, Barcelona, Spain  Lakeland Regional Medical Center, Lakeland, FL  University of Pennsylvania, Philadelphia, PA  Hannover Medical School, Hanover, Germany  University of Oxford, Oxford, United Kingdom  Bicetre University Hospital, Le Kremlin-Bicetre, France  argenx, Bierbeek, Belgium  Kyushu University Hospital, Fukuoka City, Japan  Erasmus University Medical Center, Rotterdam, Netherlands  Cedars-Sinai Medical Center, Los Angeles, CA  

              CD163+ Microglia-Macrophages in the Multiple Sclerosis Spinal Cord Associate with Aberrant Iron Distribution and Indicate Blood Brain Barrier Dysfunction

              Author:Lockhart, Andrew   Zhang, Xinran   Pisa, Marco   Avery, Aimee   Pansieri, Jonathan   Drakesmith, Hal   De Luca, Gabriele   

              Session Name:S33: Multiple Sclerosis: Biomarkers in MS  

              Topic:Multiple Sclerosis  

              Program Number:S33.008  

              Author Institution:Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom  University of Oxford, Oxford, United Kingdom  

              Oral Cladribine Capsules for Generalized Myasthenia Gravis: Design of the Actively Recruiting Phase 3 MyClad Study

              Author:Rejdak, Konrad   Howard Jr., James F.   Cutter, Gary   O'Connor, Kevin   Dimachkie, Mazen   Palace, Jacqueline   Meisel, Andreas   Mantegazza, Renato   Nolting, Axel   Gopalakrishnan, Sathej   Le Bolay, Claire   Javor, Andrija   Alexandri, Nektaria   Jack, Dominic   Kaminski, Henry   

              Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P1.013  

              Author Institution:Medical University of Lublin, Lublin, Poland  University of Alabama at Birmingham, Birmingham, AL  Yale School of Medicine, Yale University , New Haven, CT  University of Kansas Medical Center, Kansas City, KS  University of Oxford, Oxford, United Kingdom  Charité – Universitätsmedizin Berlin, Berlin, Germany  IRCCS Carlo Besta, Milan, Italy  The healthcare business of Merck KGaA, Darmstadt, Germany, Darmstadt, Germany  Merck Santé S.A.S., an affiliate of the healthcare business of Merck KGaA, Darmstadt, Germany, Lyon, France  Ares Trading SA, an affiliate of the healthcare business of Merck KGaA, Darmstadt, Germany, Eysins, Switzerland  Merck Serono Ltd., an affiliate of the healthcare business of Merck KGaA, Darmstadt, Germany, Middlesex, United Kingdom  School of Medicine and Health Sciences, George Washington University, Washington, DC  

              Capturing What Matters: Patient Reported LGI1-ANTibody Encephalitis Outcome RatiNg Scale (LANTERN)

              Author:Kelly, Mark   Wagner, Barbara   Ceronie, Bryan   Strippel, Christine   Lin, Ann   Handel, Adam   Soltys, John   Binks, Sophie   Irani, Sarosh   Powell, Philip   

              Session Name:P9: Autoimmune Neurology: Autoimmune Encephalitis 2  

              Topic:Autoimmune Neurology  

              Program Number:P9.006  

              Author Institution:Royal College of Surgeons in Ireland, Dublin 2, Ireland  University of Oxford, Oxford, United Kingdom  Mayo Clinic, Jacksonville, FL  

              Treatment Impact of Efgartigimod PH20 SC on I-RODS Daily Activity Assessment in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: Post Hoc Analysis of the Registrational ADHERE Study

              Author:Allen, Jeffrey   Lin, Jie   Stettner, Mark   Merkies, Ingemar   Guptill, Jeffrey   Gwathmey, Kelly   Istas, Geoffrey   De Roeck, Arne   Kuwabara, Satoshi   Lauria, Giuseppe   Querol, Luis   Suresh, Niraja   Karam, Chafic   Skripuletz, Thomas   Rinaldi, Simon   Echaniz-Laguna, Andoni   V,   

              Session Name:P10: Neuromuscular and Clinical Neurophysiology (EMG): Acquired Neuropathies 2  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P10.025  

              Author Institution:UMN, Minneapolis, MN  Fudan University, Shanghai, China, People's Republic of  University Medicine Essen, Essen, Germany  Curacao Medical Center, Willemstad, Netherlands Antilles  Duke University, Durham, NC  VCU Neuroscience, Orthopedic, and Wellness, Henrico, VA  argenx, Ghent, Belgium  Chiba University, Chiba, Japan  Istituto Neurologico Carlo Besta, Milan, Italy  Hospital de la Santa Creu i Sant Pau, Barcelona, Spain  Lakeland Regional Medical Center, Lakeland, FL  University of Pennsylvania, Philadelphia, PA  Hannover Medical School, Hanover, Germany  University of Oxford, Oxford, United Kingdom  Bicetre University Hospital, Le Kremlin-Bicetre, France  argenx, Bierbeek, Belgium  Kyushu University Hospital, Fukuoka City, Japan  Erasmus University Medical Center, Rotterdam, Netherlands  Cedars-Sinai Medical Center, Los Angeles, CA